Health Condition 1: M791- Myalgia
Conditions
Interventions
Intervention1: Rupatadine and Aceclofenac CR: Rupatadine 10 mg once daily and Aceclofenac CR 200 mg once daily for two months
Control Intervention1: Aceclofenac CR: Aceclofenac CR 200 mg once daily fo
Sponsors
SRM Institute of Science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group 18-60 years 2. Subjects with Chronic Low Back Pain more than three months, Visual analog scale more than 40 mm 3. Both genders 4. Patients willing to give consent
Exclusion criteria
Exclusion criteria: 1. History of acute fracture 2. History of malignancy or neurological deficit or severe leg pain mandating surgery 3. History of lumbar disc herniation or spinal stenosis 4. History of fibromyalgia or spinal surgery 5. History of recent trauma or injury 6. History of alcohol or narcotic abuse 7. History of Peptic ulcer disease or hepatic and renal dysfunction 8. History of heart surgery 9. History of Allergy to Aceclofenac CR or H1 antagonists 10. Pregnant,lactating women 11. Psychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief to be assessedTimepoint: at the baseline, at second week, at the end of each month for two months using Visual Analog Pain Score | — |
Secondary
| Measure | Time frame |
|---|---|
| Disability and Quality of Life to be assessed by Oswestry Disability Index questionnaire,WHOQOLBREF questionnaire respectivelyTimepoint: at the baseline and at the end of the each month for two months | — |
Countries
India
Contacts
Public ContactDr Heena Goldin B
SRM Medical College SRM IST
Outcome results
None listed